Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)
Titel:
Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)
Auteur:
Faehling, Martin Schumann, Christian Christopoulos, Petros Hoffknecht, Petra Alt, Jürgen Horn, Marlitt Eisenmann, Stephan Schlenska-Lange, Anke Schütt, Philipp Steger, Felix Brückl, Wolfgang M. Christoph, Daniel C.